Skip to content

PhilClapharma

Active
Private limited companyfounded 20179 yrs activeBrusselsesteenweg 77, 3080 Tervuren, BelgiumKBO/BCE: BE 0675.782.469
Summary

PhilClapharma has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €319,756 and a net result of €36,909. Equity is growing by ~21.2% per year across the filed fiscal years. Its solvency ranks better than 54% of 26043 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.9% (low).

Checked score

Score 2024
Axes · tick = 2023
Profitability74▼-2
Solvency62▲+5
Growth52=
Track record100
Bankruptcy probability, 12 months
0.9% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €21,000 at 30 days acceptable
Liquidity short (current ratio 0.11 against 0.11 in 2023; short-term debt: 12.8% and cash: 1% of total assets), and 63.2% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 28-06-2025, 33 days ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
not confirmed
2024
33 d early
2023
37 d early
2022
28 d late
2021
18 d early
2020
17 d early
2019
7 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 14 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 17 May 2017, PhilClapharma was incorporated.1 Total assets went from EUR 865,226 in 2018 to EUR 869,621 in 2024.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
€319,756▲ 13.0%
2023 · €282,847
Total assets
€869,621▼ 0.7%
2023 · €875,649
Net result
€36,909▼ 23.7%
2023 · €48,362
Working capital
-€98,962▼ 13.3%
2023 · -€87,356
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202021202220232024
Operating result€61,078▲ 7.1%€66,477▲ 8.8%€70,079▲ 5.4%€70,560▲ 0.7%€60,541▼ 14.2%
Net result€36,632above the sector's middle half▲ 16.1%€41,298above the sector's middle half▲ 12.7%€41,296above the sector's middle half=€48,362above the sector's middle half▲ 17.1%€36,909above the sector's middle half▼ 23.7%
Equity€151,890above the sector's middle half▲ 31.8%€193,188above the sector's middle half▲ 27.2%€234,484above the sector's middle half▲ 21.4%€282,847above the sector's middle half▲ 20.6%€319,756above the sector's middle half▲ 13.0%
Total assets€862,095above the sector's middle half▼ 1.1%€854,122above the sector's middle half▼ 0.9%€843,254above the sector's middle half▼ 1.3%€875,649above the sector's middle half▲ 3.8%€869,621above the sector's middle half▼ 0.7%
Debt€710,205▼ 6.1%€660,934▼ 6.9%€608,769▼ 7.9%€592,802▼ 2.6%€549,865▼ 7.2%
Working capital-€88,462below the sector's middle half▲ 5.9%-€92,551below the sector's middle half▼ 4.6%-€95,198below the sector's middle half▼ 2.9%-€87,356below the sector's middle half▲ 8.2%-€98,962below the sector's middle half▼ 13.3%
Solvency17.6%within the sector's middle half▲ 4.4pp22.6%within the sector's middle half▲ 5.0pp27.8%within the sector's middle half▲ 5.2pp32.3%within the sector's middle half▲ 4.5pp36.8%within the sector's middle half▲ 4.5pp
Current ratio0.22below the sector's middle half▼ 0.030.18below the sector's middle half▼ 0.040.12below the sector's middle half▼ 0.060.11below the sector's middle half▼ 0.010.11below the sector's middle half=
Return on assets (ROA)4.2%within the sector's middle half▲ 0.6pp4.8%within the sector's middle half▲ 0.6pp4.9%within the sector's middle half▲ 0.1pp5.5%within the sector's middle half▲ 0.6pp4.2%within the sector's middle half▼ 1.3pp
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20,000€40,000€60,000€80,000Operating result 2020: €61,078€61,078Net result 2020: €36,632€36,632Operating result 2021: €66,477€66,477Net result 2021: €41,298€41,298Operating result 2022: €70,079€70,079Net result 2022: €41,296€41,296Operating result 2023: €70,560€70,560Net result 2023: €48,362€48,362Operating result 2024: €60,541€60,541Net result 2024: €36,909€36,90920202021202220232024€0€20,000€40,000€60,000€80,000Operating result 2022: €70,079€70,100Net result 2022: €41,296€41,300Operating result 2023: €70,560€70,600Net result 2023: €48,362€48,400Operating result 2024: €60,541€60,500Net result 2024: €36,909€36,900202220232024
The operating result falls in 2024; 2024 is 14% below 2023 and is the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €869,621
Fixed assets €857,109 ▼ 0.9%
Current assets €12,513 ▲ 14.6%
Equity and liabilities €869,621
Equity €319,756 ▲ 13.0%
Debt €549,865 ▼ 7.2%
Debt's share of the balance-sheet total falls from 67.7% to 63.2%. Equity is higher and debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€68,162▼
2023 · €70,769
Cash flow
€44,530▼
2023 · €48,571
Debt to equity
1.72▼
2023 · 2.10
ROE
11.5%▼
2023 · 17.1%
Interest coverage
7.54▼
2023 · 8.18
Debt ≤ 1 year
€111,474▲
2023 · €98,276
Debt > 1 year
€438,391▼
2023 · €493,064
Income taxes
€14,597▲
2023 · €13,547
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 47 lines
Balance sheet Code20232024
Assets
Total assets20/58€875,649€869,621▼
Fixed assets21/28€864,730€857,109▼
Tangible fixed assets22/27€37,895€30,274▼
Furniture and vehicles24€37,895€30,274▼
Financial fixed assets28€826,835€826,835=
Current assets29/58€10,920€12,513▲
Amounts receivable within one year40/41€1,018€1,351▲
Trade receivables40€528€861▲
Other amounts receivable41€491€491=
Cash at bank and in hand54/58€9,902€8,740▼
Deferred charges and accrued income490/1-€2,422
Equity and liabilities
Total equity and liabilities10/49€875,649€869,621▼
Equity10/15€282,847€319,756▲
Contributions10/11€30,000€30,000=
Reserves13€252,847€289,756▲
Non-distributable reserves130/1€3,000€3,000=
Reserves not available under the articles1311€3,000€3,000=
Distributable reserves133€249,847€286,756▲
Amounts payable17/49€592,802€549,865▼
Amounts payable after more than one year17€493,064€438,391▼
Financial debts170/4€373,064€318,391▼
Other amounts payable178/9€120,000€120,000=
Amounts payable within one year42/48€98,276€111,474▲
Current portion of amounts payable after more than one year42€41,040€48,390▲
Financial debts43€5,182€5,183=
Credit institutions430/8€5,182€5,183=
Trade debts44€127€2,208▲
Suppliers440/4€127€2,208▲
Taxes, remuneration and social security45€5,151€6,282▲
Taxes450/3€5,151€6,282▲
Other amounts payable47/48€46,776€49,412▲
Accrued charges and deferred income492/3€1,462-
Income statement Code20232024
Non-recurring operating income76A€6,194-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€209€7,621▲
Other operating charges640/8€916€671▼
Gross operating margin9900€71,685€68,833▼
Operating profit (loss)9901€70,560€60,541▼
Financial charges65/66B€8,651€9,035▲
Recurring financial charges65€8,651€9,035▲
Non-recurring financial charges66B€0-
Profit (loss) for the period before taxes9903€61,909€51,507▼
Income taxes67/77€13,547€14,597▲
Profit (loss) for the period9904€48,362€36,909▼
Profit (loss) for the period to be appropriated9905€48,362€36,909▼
Appropriation of the result
Profit (loss) to be appropriated9906€48,362€36,909▼
Transfer to equity691/2€48,362€36,909▼
To other reserves6921€48,362€36,909▼

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20202021202220232024Change
Non-recurring operating income76A---€6,194--
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,434€3,434€3,434€209€7,621▲ 3,550%
Other operating charges640/8-€734€620€916€671▼ 26.8%
Gross operating margin9900€65,131€70,644€74,133€71,685€68,833▼ 4.0%
Operating profit (loss)9901€61,078€66,477€70,079€70,560€60,541▼ 14.2%
Financial charges65/66B-€9,866€14,273€8,651€9,035▲ 4.4%
Recurring financial charges65€10,842€9,866€14,262€8,651€9,035▲ 4.4%
Non-recurring financial charges66B--€11€0--
Profit (loss) for the period before taxes9903€50,236€56,610€55,806€61,909€51,507▼ 16.8%
Income taxes67/77€13,604€15,312€14,509€13,547€14,597▲ 7.8%
Profit (loss) for the period9904€36,632€41,298€41,296€48,362€36,909▼ 23.7%
Profit (loss) for the period to be appropriated9905€36,632€41,298€41,296€48,362€36,909▼ 23.7%
Line20202021202220232024Change
Assets
Total assets20/58€862,095€854,122€843,254€875,649€869,621▼ 0.7%
Fixed assets21/28€837,136€833,702€830,269€864,730€857,109▼ 0.9%
Tangible fixed assets22/27€10,301€6,867€3,434€37,895€30,274▼ 20.1%
Furniture and vehicles24-€6,867€3,434€37,895€30,274▼ 20.1%
Financial fixed assets28€826,835€826,835€826,835€826,835€826,835=
Current assets29/58€24,959€20,420€12,985€10,920€12,513▲ 14.6%
Amounts receivable within one year40/41€12,118€6,158€11,304€1,018€1,351▲ 32.7%
Trade receivables40-€6,158€10,813€528€861▲ 63.1%
Other amounts receivable41--€491€491€491=
Cash at bank and in hand54/58€12,841€14,261€1,681€9,902€8,740▼ 11.7%
Deferred charges and accrued income490/1----€2,422-
Equity and liabilities
Total equity and liabilities10/49€862,095€854,122€843,254€875,649€869,621▼ 0.7%
Equity10/15€151,890€193,188€234,484€282,847€319,756▲ 13.0%
Contributions10/11€30,000€30,000€30,000€30,000€30,000=
Reserves13€121,890€163,188€204,484€252,847€289,756▲ 14.6%
Non-distributable reserves130/1-€3,000€3,000€3,000€3,000=
Reserves not available under the articles1311-€3,000€3,000€3,000€3,000=
Distributable reserves133-€160,188€201,484€249,847€286,756▲ 14.8%
Amounts payable17/49€710,205€660,934€608,769€592,802€549,865▼ 7.2%
Amounts payable after more than one year17€585,956€542,828€500,104€493,064€438,391▼ 11.1%
Financial debts170/4-€422,828€380,104€373,064€318,391▼ 14.7%
Other amounts payable178/9-€120,000€120,000€120,000€120,000=
Amounts payable within one year42/48€113,421€112,970€108,183€98,276€111,474▲ 13.4%
Current portion of amounts payable after more than one year42-€43,127€42,724€41,040€48,390▲ 17.9%
Financial debts43-€5,037€5,037€5,182€5,183=
Credit institutions430/8-€5,037€5,037€5,182€5,183=
Trade debts44€179-€984€127€2,208▲ 1,632%
Suppliers440/4--€984€127€2,208▲ 1,632%
Taxes, remuneration and social security45-€20,716€8,432€5,151€6,282▲ 22.0%
Taxes450/3-€20,716€8,432€5,151€6,282▲ 22.0%
Other amounts payable47/48-€44,091€51,006€46,776€49,412▲ 5.6%
Accrued charges and deferred income492/3-€5,135€483€1,462--
Line20202021202220232024Change
Profit (loss) for the period9904€36,632€41,298€41,296€48,362€36,909▼ 23.7%
+ Depreciation and write-downs630€3,434€3,434€3,434€209€7,621▲ 3,550%
Operating cash flow (approximation)€40,066€44,732€44,730€48,571€44,530▼ 8.3%
Investment in fixed assets (approximation)-€0€0-€34,670€0▲ 100%
Change in cash-€1,420-€12,580€8,220-€1,162▼ 114%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
28-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
24-06
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
28-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 28 days late
2022
31-12
Financial Equity above €200,000Eq €234,484 ▲21.4%
5 profitable years in a row build equity to €234,484.
13-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
14-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Equity above €150,000Eq €151,890 ▲31.8%
3 profitable years in a row build equity to €151,890.
24-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Weakest financial yearnet €31,552 ▼41.3%
Net result drops to €31,552, the lowest in the series; recovery starts the following year.
31-12
Financial Equity above €100,000Eq €115,258 ▲37.7%
2 profitable years in a row build equity to €115,258.
29-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Tervuren · 1 establishment unit since 2017
seat establishment The establishment unit on the map
Ground area
257 m²
Building footprint
182 m²
Volume, LiDAR
1,332 m³
Parcel 24302D0003/00Z010, Flanders · tallest building 15.1 m, ±2 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
PhilClapharma
Brusselsesteenweg 77, 3080 TervurenRetail sale of pharmaceutical products
since 20172.265.203.287
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24302D0003/00Z010 Flanders 257 m² 1 · 182 m² 15.1 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2022 · 1 entry · 2,000 EUR awarded · 2,000 EUR paid
Year Entries awardedpaid
2022 1 2,000 EUR2,000 EUR
Schemes
1 entry · 2,000 EUR · 2,000 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,489 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded17-05-2017
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID 0208:0675782469
Also 9925:BE0675782469
Registered 08-09-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 29 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.